![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DISHMAN PHARMA APPROVES STOCK SPLIT IN 1:5 RATIO
DISHMAN PHARMA APPROVES STOCK SPLIT IN 1:5 RATIO
August 31, 2005
Dishman Pharmaceuticals & Chemicals Ltd on Wednesday said that it would split equity shares of the company in 1:5 ratio. The board of directors have decided to split each of the existing issued, subscribed and paid-up 1,37,33,500 equity shares of the face value of Rs 10 each into five equity shares of the face value of Rs 2 each credited as fully paid up, the company informed the Bombay Stock Exchange.
Hindu Business Line (http://www.thehindubusinessline.com/blnus/02311506.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct